← All publications

Type II kinase inhibitors that target Parkinson's disease-associated LRRK2

Raig ND, Surridge KJ, Sanz-Murillo M, … Knapp S · Sci Adv 11(23):eadt2050 (2025)

How AssayQuant was used: This publication cites AssayQuant's PhosphoSens® technology.

LRRK2 assay → Ser/Thr kinase Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Read the paper View on PubMed

Cookie Settings / Do Not Sell or Share My Personal Information